Life expectancy of follicular lymphoma patients in complete response at 30 months is similar to that of the Spanish general population

British Journal of Haematology
L MagnanoGrupo Español de Linfomas y Trasplante Autólogo de Médula Ósea (GELTAMO)

Abstract

The use of immunochemotherapy has improved the outcome of follicular lymphoma (FL). Recently, complete response at 30 months (CR30) has been suggested as a surrogate for progression-free survival. This study aimed to analyse the life expectancy of FL patients according to their status at 30 months from the start of treatment in comparison with the sex and age-matched Spanish general population (relative survival; RS). The training series comprised 263 patients consecutively diagnosed with FL in a 10-year period who needed therapy and were treated with rituximab-containing regimens. An independent cohort of 693 FL patients from the Grupo Español de Linfomas y Trasplante Autólogo de Médula Ósea (GELTAMO) group was used for validation. In the training cohort, 188 patients were in CR30, with a 10-year overall survival (OS) of 53% and 87% for non-CR30 and CR30 patients, respectively. Ten-year RS was 73% and 100%, showing no decrease in life expectancy for CR30 patients. Multivariate analysis indicated that the FL International Prognostic Index was the most important variable predicting OS in the CR30 group. The impact of CR30 status on RS was validated in the independent GELTAMO series. In conclusion, FL patients treated with immuno...Continue Reading

References

Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·B D ChesonG P Canellos
Jun 12, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S MontotoE Montserrat
May 6, 2004·Blood·Philippe Solal-CélignyEmili Montserrat
Apr 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Qi LiuPeter McLaughlin
Jan 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Harmonization Project on Lymphoma
Mar 27, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Massimo FedericoMaura Brugiatelli
Sep 21, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Junhee PyoAnnick D Van den Abbeele
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonT Andrew Lister
Mar 3, 2015·Leukemia & Lymphoma·Steven E CoutréAndrew D Zelenetz
Jul 1, 2015·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Carla CasuloJonathan W Friedberg
Oct 21, 2016·American Journal of Hematology·Matthew J MaurerBrian K Link
Aug 25, 2016·Biometrics·Peter Sasieni, Adam R Brentnall
Dec 29, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Qian ShiDaniel J Sargent
May 12, 2017·PloS One·Mariano ProvencioUNKNOWN GOTEL (Spanish Lymphoma Oncology Group)
Oct 28, 2017·Cancer Medicine·Ana Jiménez-UbietoUNKNOWN GELTAMO (Grupo Español de Linfomas y Trasplantes de Médula Ósea) cooperative study group
Nov 3, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Stefano LuminariMassimo Federico

❮ Previous
Next ❯

Citations

Jul 17, 2018·International nursing review·E López-CerdáM A Rodríguez-Borrego
Nov 9, 2019·Hematological Oncology·Kitsada WudhikarnUNKNOWN Thai Lymphoma Study Group
Dec 14, 2019·Nature Reviews. Disease Primers·Antonino CarboneJude Fitzgibbon
Jan 8, 2021·Journal of Hematology & Oncology·Melissa LumishErel Joffe
Feb 23, 2021·Drugs·Michael Northend, William Townsend
Jun 27, 2020·Hematology/oncology Clinics of North America·Ciara L Freeman, Laurie H Sehn
Jul 18, 2021·PharmacoEconomics·Caitlin EichtenRichard T Maziarz
Sep 12, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Sara Alonso-ÁlvarezMassimo Federico

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Annals of Oncology : Official Journal of the European Society for Medical Oncology
A SuredaGrupo Español de Linfomas/Trasplante Autólogo de Médula Osea Cooperative Group
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
A SuredaGrupo Español de Linformas/Transplante Autólogo de Médula Osea Spanish Cooperative Group
Hematological Oncology
A Jiménez-UbietoGELTAMO (Grupo Español de Linfomas y Trasplantes de Médula Ósea) Cooperative Study Group
Annals of Oncology : Official Journal of the European Society for Medical Oncology
M ConstansGEL/TAMO Cooperative Group
© 2022 Meta ULC. All rights reserved